PNPLA3 rs738408: Understanding Liver Fat and Genetic Risk
The rs738408 variant is a genetic marker located within the PNPLA3 gene, which is widely studied for its association with liver fat content and metabolic health. It is frequently analyzed alongside the well-known I148M mutation, as both are linked to the development of metabolic dysfunction-associated steatotic liver disease (MASLD).
What each genotype means
Typical liver fat profile
This genotype represents the most common version of this genetic marker. Research indicates that individuals with this profile do not carry the specific genetic risk factor associated with increased hepatic fat accumulation linked to the PNPLA3 gene.
This is the most common genotype in most populations, though frequencies vary significantly by ancestry.
Increased liver fat risk
Carrying one copy of this variant is associated with a higher statistical likelihood of increased liver fat fraction and elevated liver enzyme levels compared to those without the variant. This variant is often studied alongside the I148M protein change, which is known to influence how the liver processes and stores triglycerides.
This genotype is common, appearing in approximately 1 in 2 people of European ancestry, though it is less frequent in other populations.
Higher liver fat risk
Individuals with two copies of this variant have a statistically higher association with increased liver fat content and potential progression of metabolic dysfunction-associated steatotic liver disease. Research suggests this variant may alter lipid metabolism in the liver, and carriers should discuss liver health monitoring with their healthcare provider.
This genotype is found in a smaller subset of the population compared to the heterozygous state, with prevalence varying by ethnic background.
What is the rs738408 Variant?
The rs738408 variant is a single nucleotide polymorphism (SNP) situated within the PNPLA3 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is located in an intronic region, meaning it sits within a non-coding part of the gene. While it does not directly change the protein sequence itself, it is often studied because it exists in linkage disequilibrium with other functional variants, most notably the I148M mutation. Linkage disequilibrium means that rs738408 and the I148M variant are frequently inherited together. Because of this close physical proximity on the chromosome, researchers often use rs738408 as a proxy or marker to track the presence of the associated I148M mutation, which is known to influence how the liver processes and stores fats.
The Role of the PNPLA3 Gene
The PNPLA3 gene provides instructions for making a protein called adiponutrin, which is primarily expressed in the liver and adipose tissue. This protein plays a critical role in lipid metabolism, specifically in the breakdown and remodeling of triglycerides. When the PNPLA3 gene functions normally, it helps regulate the balance of fat storage and mobilization within liver cells. However, research indicates that certain variants in this gene, particularly those linked to the I148M change, result in a loss of normal enzymatic function. This impairment can lead to the accumulation of triglycerides within hepatocytes, the primary cells of the liver. By disrupting the normal hydrolysis of fats, the variant protein contributes to the development of hepatic steatosis, or fatty liver, which is a hallmark of metabolic dysfunction-associated steatotic liver disease (MASLD).
Research and Clinical Associations
Scientific research has consistently identified the PNPLA3 region as a major genetic determinant for liver fat content. Studies have shown that individuals carrying specific alleles at this locus exhibit higher levels of hepatic fat and elevated liver enzymes, such as ALT, which are markers of liver stress. The evidence linking this genetic region to the spectrum of MASLD—ranging from simple steatosis to more severe conditions like steatohepatitis and fibrosis—is considered strong in the scientific community. Interestingly, some recent studies suggest a paradoxical effect where this variant may be associated with reduced cardiovascular disease risk, despite its negative impact on liver health. It is important to note that while these statistical associations are robust, they represent population-level trends. Genetic risk is only one piece of the puzzle, and environmental factors like diet, exercise, and alcohol consumption play significant roles in liver health.
Population Frequency and Interpretation
The rs738408 variant is relatively common, with a minor allele frequency (MAF) of approximately 0.25 in European cohorts. This means that a significant portion of the population carries at least one copy of the variant allele. Because it is common, it is considered a normal variation in the human genome rather than a rare disease-causing mutation. When interpreting this information, it is essential to understand that having a specific genotype does not guarantee the development of liver disease. Instead, it indicates a genetic predisposition that may interact with lifestyle factors. Readers should view this information as a tool for understanding their biological background rather than a medical diagnosis. If you have concerns about your liver health or metabolic markers, the most appropriate step is to consult with a healthcare professional who can evaluate your overall clinical picture.
How common is this variant?
The rs738408 variant is common, with a minor allele frequency of approximately 0.25 in European populations, meaning many individuals carry at least one copy of the variant.
Frequently asked questions
Does having the PNPLA3 variant mean I have liver disease?
No, having this variant does not mean you have liver disease. It is a genetic predisposition that may increase your risk, but lifestyle factors like diet and exercise are major contributors to liver health.
Can I change my genetic risk for liver fat?
You cannot change your DNA, but you can manage your health through lifestyle choices. Maintaining a healthy weight and balanced diet can help mitigate the risks associated with genetic predispositions.
Should I get tested for the PNPLA3 variant?
Genetic testing for this variant is generally not recommended for the general public. If you are concerned about your liver health, speak with a doctor about standard clinical tests like blood panels or imaging.
Is this variant related to alcohol-induced liver disease?
Research suggests that PNPLA3 variants can influence liver health across various causes, including metabolic dysfunction. Always discuss your specific health history and risk factors with a medical professional.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs738408?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PNPLA3
The p.Ile148Met variant in PNPLA3 is a major genetic determinant of hepatic fat content and NAFLD risk.
This variant is in high linkage disequilibrium with the I148M (rs738409) variant, which is a major genetic determinant of hepatic fat content and susceptibility to NAFLD.
The PNPLA3 S453I variant is a rare variant associated with hepatic lipid metabolism; note that the common risk variant for NAFLD is rs738409.
An intronic variation in linkage disequilibrium with the major PNPLA3 non-alcoholic fatty liver disease (NAFLD) locus that contributes to individual liver fat accumulation and fibrosis predisposition.
The PNPLA3 I148M variant is a major genetic risk factor for non-alcoholic fatty liver disease (NAFLD) and progression to cirrhosis.
This variant is associated with increased risk of non-alcoholic fatty liver disease and liver fat accumulation.